|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$401,483
|
N/A
|
National Cancer Institute
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
$152,657
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-09S3
|
$1,375,035
|
$1,375,035
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-09
|
$26,766,352
|
$26,766,352
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia
|
5R01CA133379-03
|
$341,161
|
$85,290
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mechanisms of T cell leukemia induction and maintenance
|
5R01CA149655-02
|
$340,155
|
$340,155
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Modifiers of Notch stability and their role in cancer
|
5R21CA141399-02
|
$178,275
|
$178,275
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$797,394
|
$79,739
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Protein Kinase C and GSTP1 interactions in glioma drug resistance
|
5R01CA127872-04
|
$313,989
|
$156,995
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying B
|
1R01CA154489-01A1
|
$326,398
|
$326,398
|
ALLEN, CARL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
5R01CA098285-08
|
$490,125
|
$490,125
|
ALT, FREDERICK
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,066,163
|
$1,066,163
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-42S1
|
$125,781
|
$1,258
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-42
|
$2,401,347
|
$24,013
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma
|
1R01CA151533-01A1
|
$327,850
|
$163,925
|
AMIN, HESHAM
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-09
|
$5,780,843
|
$5,780,843
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
General Descriptive Studies
|
ZIA CP010183-00350
|
$77,845
|
$7,785
|
Anderson, Bill
|
DCEG (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$273,950
|
$273,949
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$328,740
|
$164,369
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$219,160
|
$87,663
|
Aplan, Peter
|
CCR (NCI)
|
|
Genetic Predictors of AML Treatment Response
|
5R01CA133881-02
|
$572,691
|
$572,691
|
Aplenc, Richard
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
5R01CA140575-02
|
$347,535
|
$347,535
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Long-term Treatment Related CNS Injury in Survivors of Childhood Cancer
|
5R21CA138988-02
|
$178,725
|
$178,725
|
Armstrong, Gregory
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$60,744
|
$12,148
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$425,206
|
$170,082
|
Arthur, Diane
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-25
|
$2,133,222
|
$42,664
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$85,103
|
$17,020
|
Avital, Itzhak
|
CCR (NCI)
|
|
Normal & Neoplastic Growth in the Brain
|
3P01CA096832-08S1
|
$90,492
|
$90,492
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-32S1
|
$665,444
|
$6,654
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Normal & Neoplastic Growth in the Brain
|
5P01CA096832-08
|
$1,932,357
|
$1,932,357
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Pten and P13K regulation of growth and neoplasia in the brain
|
5R01CA135554-09
|
$389,271
|
$194,636
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-02
|
$338,142
|
$338,142
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-32
|
$8,893,886
|
$88,939
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-27
|
$2,878,195
|
$28,782
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Cancer Survivorship: Telling a Story through the Eyes of "Esperanza" (HOPE) appl
|
5P20CA157064-02
|
$128,642
|
$128,642
|
Barboa, Elvia
|
PARENTS AGAINST CANCER
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$125,979
|
$125,978
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$125,979
|
$125,978
|
Barr, Frederic
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA042014-22S1
|
$75,000
|
$2,250
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-22
|
$1,409,422
|
$42,283
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Development of cambinol analogues as antilymphoma agents
|
5R01CA129132-04
|
$354,244
|
$177,122
|
BEDALOV, ANTONIO
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Iowa Oncology Research Association
|
5U10CA035101-26
|
$822,579
|
$115,161
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Focal Adhesion Kinase (FAK) in Human Neuroblastoma
|
5K08CA118178-06
|
$134,533
|
$134,533
|
BEIERLE, ELIZABETH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-02
|
$245,672
|
$245,672
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
$669,875
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
$4,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
2P30CA022453-29
|
$2,553,798
|
$204,304
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-29S1
|
$50,000
|
$4,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-29S2
|
$75,000
|
$6,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-29S3
|
$140,000
|
$11,200
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-18
|
$542,939
|
$103,158
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
Total relevant funding to Childhood Cancers for this search: $195,529,112
|